Autres langues 10x Genomics, Inc.

Actions

TXG

US88025U1097

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 12/05/2026			Varia. 5j.	Varia. 1 janv.
20,92 ^USD	+2,05 %		-4,95 %	+28,26 %

12/05	10X GENOMICS, INC. : Morgan Stanley maintient sa recommandation neutre	ZM
08/05	10X GENOMICS, INC. : Deutsche Bank Securities est neutre	ZM

Autres langues

08/05	10x Genomics : First Quarter 2026 Prepared Remarks
07/05	Earnings Flash (TXG) 10x Genomics, Inc. Reports Q1 Revenue $150.8M, vs. FactSet Est of $146.4M
07/05	10x Genomics: Q1 Earnings Snapshot
07/05	10x Genomics Reports First Quarter 2026 Financial Results
07/05	10x Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
29/04	10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
29/04	The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
19/04	10x Genomics : Introduces Atera
19/04	10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
19/04	10x Genomics Introduces Atera Platform
31/03	10x Genomics Shares Rise After William Blair Upgrade
25/03	Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
17/03	PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
19/02	10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
13/02	10x Genomics : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
12/02	(TXG) 10x Genomics Expects 2026 Revenue Range $600M-$625M, vs. FactSet Est of $611.6M
12/02	10x Genomics Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set
12/02	10x Genomics: Q4 Earnings Snapshot
12/02	Earnings Flash (TXG) 10x Genomics, Inc. Reports Q4 Revenue $166.0M, vs. FactSet Est of $159.7M
12/02	10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
12/02	10X Genomics, Inc. Provides Earnings Guidance for the Full Year 2026
12/02	10x Genomics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
04/02	PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology
04/02	Pharosai and 10X Genomics Partner to Transform Cancer Research with Ai and Spatial Biology
04/02	10x Genomics, PharosAI Enter Cancer Research Partnership